This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Dexamethasone

Read time: 1 mins
Marketing start date: 26 Jan 2025

Summary of product characteristics


Effective Time

20240330

Version

2

Spl Product Data Elements

Dexamethasone Dexamethasone DEXAMETHASONE DEXAMETHASONE LACTOSE MONOHYDRATE MAGNESIUM STEARATE STARCH, CORN SUCROSE white to off-white 1735

Application Number

ANDA216283

Brand Name

Dexamethasone

Generic Name

Dexamethasone

Product Ndc

70771-1701

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1701-1 Dexamethasone Tablets, USP 2 mg 100 Tablets Rx only Zydus dexamethasone 2mg

Spl Unclassified Section

SPL UNCLASSIFIED

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.